DNA methylation profiling in human lung tissue identifies genes associated with COPD

Area of Science:

• Pulmonary Medicine
• Genetics
• Epigenetics

Background:

• Chronic obstructive pulmonary disease (COPD) is a complex smoking-related lung disease with significant genetic and phenotypic heterogeneity.
• Genetic variations partially explain COPD susceptibility, highlighting the need for epigenetic investigations.

Purpose of the Study:

• To perform genome-wide DNA methylation profiling in lung tissue from COPD patients and controls.
• To integrate differentially methylated loci with existing genome-wide association study (GWAS) data to identify genes involved in COPD pathogenesis.

Main Methods:

• Genome-wide DNA methylation profiling was conducted on homogenized lung tissue from 46 controls and 114 COPD subjects (all former smokers).
• Differentially methylated loci were identified and intersected with previous GWAS results.
• Pathway analysis was performed on identified differentially methylated sites.

Main Results:

• 535 differentially methylated sites (≥5% mean difference) were identified, enriched for CpG shelves and shores.
• Pathway analysis revealed enrichment for transcription factors.
• Key genes identified at the intersection of differential methylation and GWAS include CHRM1, GLT1D1, C10orf11, FRMD4A, and THSD4.

Conclusions:

• Epigenetic association studies, particularly DNA methylation profiling, complement genetic studies in identifying potential COPD pathogenesis genes.
• Enrichment for genes implicated in asthma, lung function, and transcription factors suggests the pathogenic relevance of identified epigenetic alterations.